Search research articles
Contact Us
Filters
Showing results (571-580 of 692) with videos related to
Page
of 70
Sort By:
Cancer Cell
|
January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
Astrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2006
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study
Gerarda J M Herder, Henk Kramer, Otto S Hoekstra, et al.
Neuro-Oncology
|
August 7, 2024
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study
J W Tijmen van der Wel, Mirjam C Boelens, Merel Jebbink, et al.
Virchows Archiv : an International Journal of Pathology
|
October 16, 2012
Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma
Erik Thunnissen, Evan Boers, Daniëlle A M Heideman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Jules L Derks, Noémie Leblay, Erik Thunnissen, et al.
Interactive Cardiovascular and Thoracic Surgery
|
November 4, 2021
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis
Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography
Astrid A M van der Veldt, Mark Lubberink, Ron H J Mathijssen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2013
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis
N E Verstegen, J W A Oosterhuis, D A Palma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
John T Maringwa, Chantal Quinten, Madeleine King, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2021
PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Jasper Smit, Frank J Borm, Anna-Larissa N Niemeijer, et al.
Page
of 70
Search research articles
Search
Showing results (571-580 of 692) with videos related to
Sort By:
Page
of 70
Cancer Cell
|
January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
Astrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2006
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study
Gerarda J M Herder, Henk Kramer, Otto S Hoekstra, et al.
Neuro-Oncology
|
August 7, 2024
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study
J W Tijmen van der Wel, Mirjam C Boelens, Merel Jebbink, et al.
Virchows Archiv : an International Journal of Pathology
|
October 16, 2012
Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma
Erik Thunnissen, Evan Boers, Daniëlle A M Heideman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Jules L Derks, Noémie Leblay, Erik Thunnissen, et al.
Interactive Cardiovascular and Thoracic Surgery
|
November 4, 2021
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis
Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography
Astrid A M van der Veldt, Mark Lubberink, Ron H J Mathijssen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2013
Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis
N E Verstegen, J W A Oosterhuis, D A Palma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
John T Maringwa, Chantal Quinten, Madeleine King, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 13, 2021
PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Jasper Smit, Frank J Borm, Anna-Larissa N Niemeijer, et al.
Page
of 70